fbpx Back to Top

Cutaneous T-Cell Lymphoma

Get Help with Your Treatment

Apply Online or call 1-866-316-7263

 

Program Status

Program Fully Allocated

Currently Closed – We are no longer accepting or processing applications for new or renewal patients.

 

The PAN Foundation’s Cutaneous T-cell Lymphoma fund is currently closed. As of November 20, 2019, National Organization for Rare Disorders is accepting applications.

 

For current information, log in to FundFinder.

Assistance Amount

$8,000 per year. Patients may apply for a second grant during their eligibility period subject to availability of funding.

Eligibility Criteria

  1. The patient must be getting treatment for cutaneous T-cell lymphoma.
  2. The patient must have health insurance that covers his or her qualifying medication or product.
  3. The patient’s medication or product must be listed on PAN’s list of covered medications.
  4. The patient’s income must fall at or below 500% of the Federal Poverty Level.
  5. The patient must reside and receive treatment in the United States or U.S. territories. (U.S. citizenship is not a requirement.)
list icon
See the list of medications covered in this program
View List  
  • Absorica (isotretinoin)
  • Acitretin (acitretin)
  • Actimmune (interferon gamma-1b,recomb.)
  • Active Injection Kit D (dexamethasone sodium phosphate/pf)
  • Adcetris (brentuximab vedotin)
  • Aldara (imiquimod)
  • Amnesteem (isotretinoin)
  • Beleodaq (belinostat)
  • Belrapzo (bendamustine hcl)
  • Bendamustine Hcl (bendamustine hcl)
  • Bendeka (bendamustine hcl)
  • Betamethasone Acetate-sod Phos (betamethasone acetate and sodium phos in sterile water/pf)
  • Betamethasone Sod Phos-acetate (betamethasone acetate/betamethasone sodium phosphate)
  • Bexarotene (bexarotene)
  • Bicnu (carmustine)
  • Bortezomib (bortezomib)
  • Campath (alemtuzumab)
  • Carboplatin (carboplatin)
  • Carmustine (carmustine)
  • Cisplatin (cisplatin)
  • Claravis (isotretinoin)
  • Cyclophosphamide (cyclophosphamide)
  • Cytarabine (cytarabine/pf)
  • Dexamethasone Intensol (dexamethasone)
  • Dexamethasone Sodium Phosphate (dexamethasone sodium phosphate)
  • Dexpak (dexamethasone)
  • Doubledex (dexamethasone sodium phosphate/pf)
  • Doxil (doxorubicin hcl pegylated liposomal)
  • Doxorubicin Hcl Liposome (doxorubicin hcl pegylated liposomal)
  • Etopophos (etoposide phosphate)
  • Etoposide (etoposide)
  • Folotyn (pralatrexate)
  • Gemcitabine Hcl (gemcitabine hcl)
  • Gemzar (gemcitabine hcl)
  • Ifex (ifosfamide)
  • Ifosfamide (ifosfamide)
  • Ifosfamide-mesna (ifosfamide/mesna)
  • Imiquimod (imiquimod)
  • Intron A (interferon alfa-2b,recomb.)
  • Isotretinoin (isotretinoin)
  • Istodax (romidepsin)
  • Keytruda (pembrolizumab)
  • Leukeran (chlorambucil)
  • Lipodox (doxorubicin hcl pegylated liposomal)
  • Matulane (procarbazine hcl)
  • Medrol (methylprednisolone)
  • Mesna (mesna)
  • Mesnex (mesna)
  • Methotrexate (methotrexate sodium)
  • Methylprednisolone (methylprednisolone)
  • Methylprednisolone Acetate (methylprednisolone acetate)
  • Methylprednisolone Sodium Succ (methylprednisolone sodium succinate)
  • Mustargen (mechlorethamine hcl)
  • Myorisan (isotretinoin)
  • Navelbine (vinorelbine tartrate)
  • Nipent (pentostatin)
  • Oncaspar (pegaspargase)
  • Oxaliplatin (oxaliplatin)
  • Poteligeo (mogamulizumab-kpkc)
  • Prednisone (prednisone)
  • Retrovir (zidovudine)
  • Revlimid (lenalidomide)
  • Rituxan (rituximab)
  • Rituxan Hycela (rituximab/hyaluronidase, human recombinant)
  • Romidepsin (romidepsin)
  • Solu-medrol (methylprednisolone sodium succinate/pf)
  • Soriatane (acitretin)
  • Targretin (bexarotene)
  • Tazorac (tazarotene)
  • Temodar (temozolomide)
  • Temozolomide (temozolomide)
  • Toposar (etoposide)
  • Treanda (bendamustine hcl)
  • Tretinoin (tretinoin)
  • Tretinoin Microsphere (tretinoin microspheres)
  • Triamcinolone Acetonide (triamcinolone acetonide)
  • Trisenox (arsenic trioxide)
  • Valchlor (mechlorethamine hcl)
  • Velcade (bortezomib)
  • Vincasar Pfs (vincristine sulfate)
  • Vinorelbine Tartrate (vinorelbine tartrate)
  • Xalkori (crizotinib)
  • Zenatane (isotretinoin)
  • Zolinza (vorinostat)

Diagnosis Codes:

ICD-10: C84.00, C84.01, C84.02, C84.03, C84.04, C84.05, C84.06, C84.07, C84.08, C84.09, C84.10, C84.11, C84.12, C84.13, C84.14, C84.15, C84.16, C84.17, C84.18, C84.19, C84.40, C84.41, C84.42, C84.43, C84.44, C84.45, C84.46, C84.47, C84.48, C84.49, C84.A0, C84.A1, C84.A2, C84.A3, C84.A3, C84.A4, C84.A5, C84.A6, C84.A7, C84.A8, C84.A9, C86.0, C86.3, C86.6, C91.50, C91.51, C91.52

 

About the Disease:

Cutaneous T-cell lymphoma (CTCL) is a type of cancer that begins in the white blood cells and attacks the skin and can also involve the blood, lymph nodes or internal organs. CTCL affects the circulatory and lymphatic systems. Subtypes include adult T-cell leukemia/lymphoma, cutaneous anaplastic large cell lymphoma, extranodal NK/T-cell lymphoma, granulomatous slack skin disease, lymphomatoid granulomatosis, lymphomatoid papulosis, mycosis fungoides, pagetoid reticulosis and peripheral T-cell lymphoma and Sézary syndrome.

 

Source: National Institutes of Health